|
|
 |
4 Opportunities for AI in Small and Rural Hospitals - 2025/05/17 - |
|
Home Administration of Long-Acting HIV Therapy is Safe, Effective - 2025/05/5 - |
|
Is the PASTEUR Act the Correct Way to Tackle Antibiotic Resistance? - 2025/01/1 - |
|
Study Finds Behaviors of Breast Cancer Cells Help Predict Risk of Bone Metastasis - 2024/11/6 - |
|
Researchers Find Lack of Communication for Lung Cancer Screenings Among High-Risk Individuals - 2024/11/6 - |
|
Pharmacists Play Key Role in Flu Vaccination Efforts - 2024/11/6 - |
|
FDA Grants Orphan Drug Designation to CAP-002 to Treat Patients With Developmental and Epileptic Encephalopathy - 2024/11/2 - |
|
Vitamin D Supplementation Could Aid Pediatric Obstructive Sleep Apnea - 2024/11/2 - |
|
Navigating FDA Compounding Regulations: Tirzepatide's Removal From the Shortage List and Its Impact on 503A and 503B Facilities - 2024/11/2 - |
|
Almost 50 hospitalised after taking weight loss drugs, warns MHRA - 2024/10/28 - |
|
NCPA 2024: Latest Updates on Respiratory Vaccines - 2024/10/28 - |
|
NCPA 2024: In Spite of Challenges, Independent Pharmacies Are Continuing to Serve Patients - 2024/10/28 - |
|
Patients With Endometriosis Have an Increased Risk of Developing Cardiovascular Disease - 2024/10/23 - |
|
Increase in Pharmacy First monthly payment threshold delayed to January 2025 - 2024/10/23 - |
|
Iron deficiency may be more common than we think - 2024/10/20 - |
|
Pharmacists to improve provision of palliative care medicines under proposed five-year strategy - 2024/10/20 - |
|
Bioelectronic 'living pharmacy' implant could transform diabetes and obesity care - 2024/10/7 - |
|
FDA Grants Orphan Drug Designation to LQT-1213 to Treat Patients With Long QT Syndrome - 2024/10/7 - |
|
Overview of the Diagnosis and Treatment of COPD Exacerbations - 2024/09/3 - |
|
Tirzepatide Shows Improvements in MASH Without Worsening Fibrosis - 2024/07/6 - |
|
The FDA Grants Accelerated Approval to Tarlatamab-dlle in Small Cell Lung Cancer - 2024/05/18 - |
|
Intravenous Ibuprofen for the Treatment of Pain and Fever: An Update - 2024/03/4 - |
|
Weight Loss Drug Compounding Enforcement Unlikely to Affect 503B Facilities - 2024/03/4 - |
|
Rising out-of-pocket costs for PrEP threaten key strategy in ending the HIV epidemic - 2024/01/15 - |
|
Iran exports pharmaceuticals to 40 countries - 2023/12/20 - |
|
Inside Insomnia: Pharmacist Management of Sleep Disorders - 2023/11/12 - |
|
FDA Approves First Vaccine to Prevent Infection from Chikungunya Virus - 2023/11/12 - |
|
FDA Approves Sotagliflozin for Treatment of Heart Failure - 2023/10/23 - |
|
Study: Monoclonal Antibodies Benefit Those Previously Treated for HIV - 2023/09/25 - |
|
Presymptomatic Atherosclerosis May Contribute to the Development of Alzheimer Disease Later in Life - 2023/09/4 - |
|
Study: COVID-19 Pandemic Associated With Worse Treatment, Outcomes in Patients With Acute Myocardial Infarction - 2023/09/4 - |
|
WHO says global childhood vaccinations closer to prepandemic levels - 2023/08/1 - |
|
Poor cardiovascular health may contribute to the development of musculoskeletal disorders - 2023/06/13 - |
|
FDA announces updates to warning for all prescription stimulants - 2023/05/24 - |
|
Cancer deaths set to decline new analysis suggests - 2023/05/6 - |
|
Study Finds No Significant Effect on Infusion Reactions, Cardiac Dysfunction When Switching from Trastuzumab to Biosimilar in HER2-Positive Breast Cancer - 2023/04/25 - |
|
Pharmacy chain appeals to older people and vulnerable to get latest Covid-19 booster - 2023/04/9 - |
|
Immunotherapies, PARP Inhibitors Show Promise in Early Stage, Triple-Negative Breast Cancers - 2023/03/26 - |
|
Statin alternative joins drugs that could reduce heart attack risk - 2023/03/26 - |
|
Female Patients Hospitalized With COVID-19 Are Less Likely to Have Cardiovascular Complications - 2023/02/20 - |
|
MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer - 2023/01/29 - |
|
Complementary, alternative therapies for heart failure have some benefits and potential risks - 2022/12/24 - |
|
Study questions HDLs in predicting CVD risk - 2022/12/12 - |
|
Pharmacists Urged to Do Their Part in Fight Against False Dietary Supplement Claims - 2022/11/27 - |
|
Data Support Use of Novavax COVID-19 Vaccine as Booster - 2022/11/16 - |
|
Capivasertib Plus Faslodex Meets Both Primary Endpoints in Phase 3 Trial for Breast Cancer - 2022/10/31 - |
|
FDA Approves Vegzelma, a Biosimilar to Bevacizumab, for Six Types of CancerFDA Approves Vegzelma, a Biosimilar to Bevacizumab, for Six Types of Cancer - 2022/09/13 - |
|
FDA Approves Oral Liquid Formulation to Treat Gastric Issues - 2022/09/3 - |
|
Common Antibiotic Associated with Rare, Severe Adverse Effects for Patients with Advanced Chronic Kidney Disease - 2022/08/17 - |
|
PCSK9 inhibitors seem to benefit those with high cardiovascular risk - 2022/08/1 - |
|
Experts release appropriate use recommendations for Alzheimer’s disease blood biomarkers - 2022/08/1 - |
|
Scientists develop an improved pharmaceutical drug for the treatment of atrial fibrillation - 2022/07/25 - |
|
CDC: COVID-19 vaccines recommended for young children - 2022/06/27 - |
|
FDA Approves Risankizumab-rzaa for Moderately to Severely Active Crohn Disease - 2022/06/21 - |
|
FDA Withdraws Umbralisib Due to Elevated Mortality Risk - 2022/06/6 - |
|
Could some arthritis drugs reduce Alzheimer and related dementias risk in those with heart disease? - 2022/05/16 - |
|
Cardiac Issues After COVID Infection and Vaccination: New Data - 2022/04/24 - |
|
FDA Panel: Concerns Over PI3K Inhibitors in Blood Cancers - 2022/04/24 - |
|
Pembrolizumab vs. placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma - 2022/04/5 - |
|
Audio Interview: Effectiveness of Covid-19 Vaccination in Children - 2022/04/5 - |
|
Compatibility of Commonly Used IV Drugs - 2022/02/20 - |
|
FDA Delays Advisory Meeting for COVID-19 Vaccine for Very Young Kids - 2022/02/13 - |
|
Omicron’s Differences, Sense of Smell, Effects on the Brain and Other News - 2022/02/13 - |
|
FDA Limits Use of Monoclonal Antibodies to Treat COVID-19 - 2022/01/26 - |
|
EHR Tool Flags Iron Deficiency In Heart Failure - 2022/01/16 - |
|
Omicron wave: 9 in 10 pharmacies struggling with staff absences - 2022/01/16 - |
|
No more annual flu shot? New target for universal influenza vaccine - 2022/01/8 - |
|
Could vitamin D deficiency increase the risk of heart disease? - 2022/01/8 - |
|
Immune Cell Population Potentially Responsible for Inflammation in Multiple Sclerosis - 2022/01/1 - |
|
Coronavirus Can Spread to Heart, Brain Days After Infection - 2021/12/29 - |
|
FDA Gives Nod to Tralokinumab for Adults With Moderate to Severe AD - 2021/12/29 - |
|
Japan Health Panel Approves Merck's Oral COVID-19 Treatment - 2021/12/28 - |
|
Positive Phase 3 Topline Results for Early Parkinson's Drug - 2021/12/28 - |
|
Abrocitinib Approved for Atopic Dermatitis in Europe - 2021/12/14 - |
|
Major COVID-19 Case Growth Expected in Coming Weeks - 2021/12/14 - |
|
Feds Go on Offense Ahead of Potential Omicron Spread in US - 2021/12/5 - |
|
New COVID Variant of Concern Drives US Travel Bans - 2021/11/27 - |
|
Anticoagulants Can Ease Cognitive Decline in AF Patients - 2021/11/27 - |
|
Pfizer Announces Agreement with US Government for COVID-19 Oral Antiviral Treatment - 2021/11/24 - |
|
CDC Director Endorses Pfizer, Moderna Boosters for All US Adults - 2021/11/20 - |
|
Stroke: Large study shows which types of fat and dietary sources lower risk - 2021/11/10 - |
|
First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA - 2021/11/6 - |
|
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5 to 11 - 2021/10/31 - |
|
Using mRNA to Create the Elusive HIV Vaccine - 2021/10/26 - |
|
High bioactivity proteins for antibody drug conjugate (ADC) development - 2021/10/19 - |
|
FDA OKs New High-Dose Naloxone Product for Opioid Overdose - 2021/10/19 - |
|
In Atopic Dermatitis Trial, Abrocitinib Offers Faster Itch Relief Than Dupilumab - 2021/10/6 - |
|
First-in-Class TYK Inhibitor Shows Durable Effect for Psoriasis - 2021/10/2 - |
|
Top Questions Answered About COVID Boosters for Your Patients - 2021/09/26 - |
|
More older adults are taking drugs that can lead to falls - 2021/09/7 - |
|
mRNA vaccines reduce risk of infection by 91% for fully vaccinated - 2021/09/7 - |
|
Long COVID Symptoms Can Persist for More Than 1 Year, Study Shows - 2021/08/30 - |
|
No Sequelae From Lab Abnormalities in Pediatric Isotretinoin Study - 2021/07/12 - |
|
CDC and Pfizer at Odds Over Need for COVID-19 Booster Shots - 2021/07/12 - |
|
Antibiotic Linked to Rise in Early-Onset Colon Cancer? - 2021/07/7 - |
|
CDC recommends pregnant women get COVID-19 vaccine - 2021/06/30 - |
|
EAS Lipid Guidance: Start High-risk Patients on Combo Drug - 2021/06/30 - |
|
Cannabis could help manage symptoms of some neurological conditions - 2021/06/27 - |
|
Long COVID’ needs to be addressed by multiple specialties - 2021/06/27 - |
|
Researchers develop new therapeutic approach for treating acute myeloid leukemia - 2021/06/22 - |
